THE INFLUENCE OF CURCUMIN NANOEMULSION DROPLET SIZE ON PHARMACOKINETIC PROFILE CURCUMIN AFTER INTRAVENOUS AND ORAL IN MALE WISTAR RATS
Background and purpose: Curcumin shows low plasma concentration after oral administration due to poor absorption, rapid metabolism, and rapid systemic elimination. To improve the bioavailability of curcumin, numerous approaches have been developed. In previous research curcumin was formulated int...
Saved in:
| Main Author: | |
|---|---|
| Format: | Theses |
| Language: | Indonesia |
| Online Access: | https://digilib.itb.ac.id/gdl/view/45236 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Institution: | Institut Teknologi Bandung |
| Language: | Indonesia |
| Summary: | Background and purpose: Curcumin shows low plasma concentration after oral
administration due to poor absorption, rapid metabolism, and rapid systemic elimination.
To improve the bioavailability of curcumin, numerous approaches have been developed. In
previous research curcumin was formulated into nanoemulsion, aimed to improve the
stability and absorption of curcumin. It is reported that particle size influences
pharmacokinetic profile of the compound, therefore this research studied the effect of
curcumin nanoemulsion droplets size on the pharmacokinetics of curcumin. Methods and
Results: Glyceryn monooleate (GMO) as an oil, cremophor RH40 as a surfactant, and
polyethylene glycol 400 (PEG 400) as a cosurfactant in ratio 1:8:1. Evaluation of curcumin
nanoemulsion was carried out including to droplets size analysis, distribution droplets size,
zeta potential, and loading efficiency. The pharmacokinetic profile of curcumin
nanoemulsion in various sizes was studied to determine the relationship between particle
size to the behavior in vivo by intravenous and oral. Rats were divided into 4 groups on
intravenous administration (droplets size of 58,73 ± 1,02 nm; 146,17 ± 2,31 nm; 235,62 ±
2,34 nm; 304,89 ± 5,57 nm) and 5 group on oral (n=4) with a variation of the same
droplets size as intravenous (groups 1-4) and emulsified curcumin (group 5). Nanoemusion
dosage given by IV is 10 mg/kg bb and 50 mg/kg bb for oral administration. Blood
samples were taken via the tail vein before the test substance and at 0,25; 0,5; 1; 2; 4; 8;
12; 24 after administration of curcumin nanoemulsion. Curcumin levels in plasma was
determined by HPLC method. Results showed that the larger droplets size has the lower
value of Cmax; AUC0-24; AUC0-?; as well as the value of tmax (the intravenous
administration). Conclusion: Droplets size of curcumin nanoemulsion affects the
pharmacokinetics of curcumin after intravenous as well as oral administrations i.e
droplets size of nanoemulsion is inversely proportional to the bioavailability.
|
|---|